Covid drug: Hetero, Cipla get DCGI nod to make Remdesivir for coronavirus treatment
The product is launched under a licensing agreement with US-based Gilead Sciences to expand the access to Covid-19 treatment in low and middle-income countries.
from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...
No comments: